Top compounds associated with response to RP11-613M10.8


Feature Type Standardized
Nominal ANOVA
mRNA YM-155 CTRPv2 pan-cancer AAC 0.21 2e-08
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.15 2e-06
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA vincristine CTRPv2 pan-cancer AAC 0.13 2e-05
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.13 2e-05
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.12 3e-05
mRNA BRD1812 CTRPv2 pan-cancer AAC 0.14 8e-05
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 9e-05
Download CSV